$科济药业-B(02_老虎社区_美港股上老虎

oxzheng
05-23

$科济药业-B(02171)$

今天大跌回调在水下10%开仓了，继续看好cart

先看到30，今年不知道能不能再翻翻

作为全球实体瘤CAR-T、通用型CAR-T的双料王者，科济药业在每一轮技术赛跑中都冲锋在前，舒瑞基奥仑赛（Claudin18.2 CAR-T）有望成为全球首款获批上市的实体瘤CAR-T产品，首款通用型CAR-T产品也有望在5年内上市。

# 恒瑞&MIRXES-B双双大涨！医药股你更看好？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":438028519706944,"tweetId":"438028519706944","gmtCreate":1747975418333,"gmtModify":1747975420721,"author":{"id":4139394047016120,"idStr":"4139394047016120","authorId":4139394047016120,"authorIdStr":"4139394047016120","name":"oxzheng","avatar":"https://static.tigerbbs.com/41141a2c4502df2032215c37e019107b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.16","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[{"themeId":"a0840c45cfc1493982723f961fd588a3","categoryId":"7ba93224048e4975aa9a5a60d7f2353b","name":"恒瑞&MIRXES-B双双大涨！医药股你更看好？","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":a0840c45cfc1493982723f961fd588a3}&rnconfig={\"headerBarHidden\": true}","description":"暗盘双双大涨的恒瑞医药(01276.HK)、MIRXES-B(02629.HK)两只医药新股，今日首日上市同样大涨！大家更看好哪只新股涨势？现在还能继续持有吗？","image":"https://static.tigerbbs.com/daf866d1771e150270397853acb79f3e"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://laohu8.com/S/02171\">$科济药业-B(02171)$ </a>&nbsp;\n今天大跌回调在水下10%开仓了，继续看好cart&nbsp;\n先看到30，今年不知道能不能再翻翻\n作为全球实体瘤CAR-T、通用型CAR-T的双料王者，科济药业在每一轮技术赛跑中都冲锋在前，舒瑞基奥仑赛（Claudin18.2 CAR-T）有望成为全球首款获批上市的实体瘤CAR-T产品，首款通用型CAR-T产品也有望在5年内上市。</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/02171\">$科济药业-B(02171)$ </a>&nbsp;\n今天大跌回调在水下10%开仓了，继续看好cart&nbsp;\n先看到30，今年不知道能不能再翻翻\n作为全球实体瘤CAR-T、通用型CAR-T的双料王者，科济药业在每一轮技术赛跑中都冲锋在前，舒瑞基奥仑赛（Claudin18.2 CAR-T）有望成为全球首款获批上市的实体瘤CAR-T产品，首款通用型CAR-T产品也有望在5年内上市。</body></html>","text":"$科济药业-B(02171)$ 今天大跌回调在水下10%开仓了，继续看好cart 先看到30，今年不知道能不能再翻翻 作为全球实体瘤CAR-T、通用型CAR-T的双料王者，科济药业在每一轮技术赛跑中都冲锋在前，舒瑞基奥仑赛（Claudin18.2 CAR-T）有望成为全球首款获批上市的实体瘤CAR-T产品，首款通用型CAR-T产品也有望在5年内上市。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/438028519706944","repostId":0,"isVote":1,"tweetType":1,"viewCount":934,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02171"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":278,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}